Control of the differentiation state and function of human epidermal Langerhans cells by cytokines in vitro
- 1 September 2001
- journal article
- research article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 15 (5) , 433-440
Abstract
Langerhans cells can originate in vitro from immature precursors stimulated with granulocyte macrophage‐colony‐stimulating factor (GM‐CSF), tumour necrosis factor (TNF)‐α and stem cell factor (SCF). We asked whether these cytokines also control the differentiation state of Langerhans cells within the epidermis and upon leaving this tissue. We harvested sheets of human epidermis by controlled dispase hydrolysis of keratomes, cultured them in RPMI and 10% fetal calf serum for 48 h and analysed the sheets and the cells migrated spontaneously into the medium, most of which were Langerhans cells containing Birbeck granules.1 By flow cytometry, the intensity of CD1a expression was reduced quite evenly among Langerhans cells migrated from sheets within 48 h. The cells in the sheets underwent loss of dendrites, with a significant reduction in the cell perimeter that was prevented by GM‐CSF and TNF‐α together. Either of these cytokines induced expression of CD18 by cells in the sheets and those in the medium. Moreover, TNF‐α induced expression of CD54 by cells in the medium, but not by those retained in the sheets, whereas human SCF induced, dose dependently, expression of CD54 by cells in the sheets, but not from those in the medium.2 The proliferation of allogeneic lymphocytes was much higher when stimulating Langerhans cells were harvested from cultures with any cytokine, rather than from cultures without cytokines. We conclude the following: (i) GM‐CSF and TNF‐α help to maintain full differentiation of Langerhans cells within the epidermis; (ii) cytokine influence on Langerhans cells adhesiveness is in part context dependent; and (iii) pretreatment with cytokines influences positively the number or accessory activity of Langerhans cells on lymphocytes during subsequent mixed leucocyte reaction.Keywords
This publication has 32 references indexed in Scilit:
- Expansion of dendritic cells derived from human CD34+ cells in static and continuous perfusion culturesBritish Journal of Haematology, 1998
- Morphological control of cell growth and viabilityBioEssays, 1997
- Generation of dendritic cell‐like antigen‐presenting cells in long‐term mixed leucocyte culture: phenotypic and functional studiesImmunology, 1997
- STEM CELL FACTOR AND THE REGULATION OF DENDRITIC CELL PRODUCTION FROM CD34+ PROGENITORS IN BONE MARROW AND CORD BLOODBritish Journal of Haematology, 1996
- Stem cell factor augments tumor necrosis factor‐granulocyte‐macrophage colony‐stimulating factor‐mediated dendritic cell hematopoiesisStem Cells, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.Journal of Experimental Medicine, 1994
- Purified human oral mucosal Langerhans cells function as accessory cells in vitroClinical and Experimental Immunology, 1993
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992
- Human Epidermal Langerhans Cells Undergo Profound Morphologic and Phenotypical Changes During In Vitro CultureJournal of Investigative Dermatology, 1990
- Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.Journal of Experimental Medicine, 1987